Cargando…
Diversity and Within-Host Evolution of Leishmania donovani from Visceral Leishmaniasis Patients with and without HIV Coinfection in Northern Ethiopia
Visceral leishmaniasis (VL) is a fatal disease and a growing public health problem in East Africa, where Ethiopia has one of the highest VL burdens. The largest focus of VL in Ethiopia is driven by high prevalence in migrant agricultural workers and associated with a high rate of coinfection with HI...
Autores principales: | Franssen, Susanne U., Takele, Yegnasew, Adem, Emebet, Sanders, Mandy J., Müller, Ingrid, Kropf, Pascale, Cotton, James A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262925/ https://www.ncbi.nlm.nih.gov/pubmed/34182785 http://dx.doi.org/10.1128/mBio.00971-21 |
Ejemplares similares
-
Impaired in vitro Interferon-γ production in patients with visceral leishmaniasis is improved by inhibition of PD1/PDL-1 ligation
por: Takele, Yegnasew, et al.
Publicado: (2022) -
Following successful anti-leishmanial treatment, neutrophil counts, CD10 expression and phagocytic capacity remain reduced in visceral leishmaniasis patients co-infected with HIV
por: Takele, Yegnasew, et al.
Publicado: (2022) -
Recurrent visceral leishmaniasis relapses in HIV co-infected patients are characterized by less efficient immune responses and higher parasite load
por: Takele, Yegnasew, et al.
Publicado: (2022) -
Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV
por: Takele, Yegnasew, et al.
Publicado: (2021) -
Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia
por: van Griensven, Johan, et al.
Publicado: (2018)